Document is current
Any future updates will be listed below
-
Authors
Estabrook, Daniel A. https://orcid.org/0000-0001-7237-6291
Huang, Lihua
Lucchese, Olivia R. https://orcid.org/0009-0009-3755-406X
Charland, Dylan J.
Yu, Zhao
Sayyed, Fareed Bhasha
Buser, Jonas Y.
Oh, Younghoon https://orcid.org/0000-0003-2454-1701
Liu, Xingyan
Johnson, Harmon A.
Rodriguez, Kenneth G. https://orcid.org/0009-0007-9444-5367
Wambolt, Noah A. https://orcid.org/0009-0006-1453-6297
Corba, Sonia A. https://orcid.org/0009-0007-0369-7762
Nash, Geoffrey T. https://orcid.org/0000-0002-1470-2279
Yang, Dennis
Wang, Tingting
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 26 August 2025
First Online: 25 September 2025
Competing interests
: At the time of the manuscript preparation all authors in this report are, or were previously, employees of Eli Lilly and Company, Indianapolis, IN. D.E., L.H., O.L., Z.Y. and T.W. have filed intellectual property related to this manuscript (including Patent No. WO2024137423A1, published but pending). D.E., L.H., D.C., Z.Y., F.B.S., J.B., Y.O., X.L., H.J., K.G.R., G.N., D.Y., and T.W. own stock in Eli Lilly and Company. N.W. and S.C. declare no competing interest.
